This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Thought organization: Difference between revisions
Jump to navigation
Jump to search
>Graham m Grammatics |
>Tracer Experience reports |
||
| (4 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
<onlyinclude>'''Thought organization''' (also known as '''fluid intelligence''')<ref>Diamond | <onlyinclude>'''Thought organization''' (also known as '''fluid intelligence''')<ref name="Diamond2013">{{cite journal|last1=Diamond|first1=Adele|title=Executive Functions|journal=Annual Review of Psychology|volume=64|issue=1|year=2013|pages=135–168|issn=0066-4308|doi=10.1146/annurev-psych-113011-143750}}</ref> is defined as a state of mind in which one's ability to analyze and categorize conceptual information using a systematic and logical thought process is considerably increased.<ref name="BiedermanSeidman2008">{{cite journal|last1=Biederman|first1=Joseph|last2=Seidman|first2=Larry J.|last3=Petty|first3=Carter R.|last4=Fried|first4=Ronna|last5=Doyle|first5=Alysa E.|last6=Cohen|first6=Daniel R.|last7=Kenealy|first7=Deborah C.|last8=Faraone|first8=Stephen V.|title=Effects of Stimulant Medication on Neuropsychological Functioning in Young Adults With Attention-Deficit/Hyperactivity Disorder|journal=The Journal of Clinical Psychiatry|volume=69|issue=7|year=2008|pages=1150–1156|issn=0160-6689|doi=10.4088/JCP.v69n0715}}</ref><ref name="Gupta1977">{{cite journal|last1=Gupta|first1=B.S.|title=Dextroamphetamine and measures of intelligence|journal=Intelligence|volume=1|issue=3|year=1977|pages=274–280|issn=01602896|doi=10.1016/0160-2896(77)90010-1}}</ref><ref name="Hellwig-BridaDaseking2011">{{cite journal|last1=Hellwig-Brida|first1=Susanne|last2=Daseking|first2=Monika|last3=Keller|first3=Ferdinand|last4=Petermann|first4=Franz|last5=Goldbeck|first5=Lutz|title=Effects of Methylphenidate on Intelligence and Attention Components in Boys with Attention-Deficit/Hyperactivity Disorder|journal=Journal of Child and Adolescent Psychopharmacology|volume=21|issue=3|year=2011|pages=245–253|issn=1044-5463|doi=10.1089/cap.2010.0041}}</ref> It seemingly occurs through reducing thoughts which are unrelated or irrelevant to the topic at hand, therefore improving one's capacity for a structured and cohesive thought stream.<ref name="BiedermanSeidman2008" /><ref name="ArnstenLi2005">{{cite journal|last1=Arnsten|first1=Amy F.T.|last2=Li|first2=Bao-Ming|title=Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions|journal=Biological Psychiatry|volume=57|issue=11|year=2005|pages=1377–1384|issn=00063223|doi=10.1016/j.biopsych.2004.08.019}}</ref> This effect also seems to allow the person to hold a greater amount of relevant information (as evidenced by language comprehension increases)<ref name="Hellwig-BridaDaseking2011" /> in their train of thought which can be useful for extended mental calculations, articulating ideas, and analyzing logical arguments. | ||
Thought organization is often accompanied by other coinciding effects such as [[analysis enhancement]] and [[thought connectivity]]. It is most commonly induced under the influence of [[dosage#light|mild]] [[dosage|dosages]] of [[stimulant]] and [[nootropic]] compounds, such as [[ | Thought organization is often accompanied by other coinciding effects such as [[analysis enhancement]] and [[thought connectivity]]. It is most commonly induced under the influence of [[dosage#light|mild]] [[dosage|dosages]] of [[stimulant]] and [[nootropic]] compounds, such as [[amphetamine]], [[methylphenidate]], and [[Noopept]]. However, this effect can occur to a lesser extent under the influence of certain [[cannabis]] strains and spontaneously during [[psychedelic]] states. It is also worth noting that the same compounds which induce this mind state at [[dosage#light|light]] to [[dosage#moderate|moderate]] [[dosage|dosages]] can often result in the opposite effect of [[thought disorganization]] at [[dosage#heavy|heavier]] dosages.<ref name="Gupta1977" /><ref name="ArnstenLi2005" /><ref name="Lundqvist2005">{{cite journal|last1=Lundqvist|first1=T|title=Cognitive consequences of cannabis use: Comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions|journal=Pharmacology Biochemistry and Behavior|volume=81|issue=2|year=2005|pages=319–330|issn=00913057|doi=10.1016/j.pbb.2005.02.017}}</ref> | ||
</onlyinclude> | </onlyinclude> | ||
===Psychoactive substances=== | ===Psychoactive substances=== | ||
Compounds within our [[psychoactive substance index]] which may cause this effect include: | Compounds within our [[psychoactive substance index]] which may cause this effect include: | ||
{{#ask:[[Category:Psychoactive substance]][[Effect::Thought organization]]|format=ul|Columns=2}} | {{#ask:[[Category:Psychoactive substance]][[Effect::Thought organization]]|format=ul|Columns=2}} | ||
===Experience reports=== | |||
Annectdotal reports which describe this effect with our [[experience index]] include: | |||
{{#ask:[[Category:Experience]][[Effect::Thought organization]]|format=ul|Columns=2}} | |||
===See also=== | ===See also=== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
| Line 14: | Line 17: | ||
*[[Deliriants#Subjective_effects|Deliriants - Subjective effects]] | *[[Deliriants#Subjective_effects|Deliriants - Subjective effects]] | ||
===External links=== | ===External links=== | ||
* [https://en.wikipedia.org/wiki/ | * [https://en.wikipedia.org/wiki/Fluid_and_crystallized_intelligence Fluid and crystallized intelligence (Wikipedia)] | ||
[[Category:Cognitive]] [[Category:Enhancement]] [[Category:Effect]] | * [https://en.wikipedia.org/wiki/Executive_functions Executive functions (Wikipedia)] | ||
===References=== | |||
<references /> | |||
[[Category:Cognitive]] | |||
[[Category:Enhancement]] | |||
[[Category:Effect]] | |||
Latest revision as of 12:43, 6 February 2020
Thought organization (also known as fluid intelligence)[1] is defined as a state of mind in which one's ability to analyze and categorize conceptual information using a systematic and logical thought process is considerably increased.[2][3][4] It seemingly occurs through reducing thoughts which are unrelated or irrelevant to the topic at hand, therefore improving one's capacity for a structured and cohesive thought stream.[2][5] This effect also seems to allow the person to hold a greater amount of relevant information (as evidenced by language comprehension increases)[4] in their train of thought which can be useful for extended mental calculations, articulating ideas, and analyzing logical arguments.
Thought organization is often accompanied by other coinciding effects such as analysis enhancement and thought connectivity. It is most commonly induced under the influence of mild dosages of stimulant and nootropic compounds, such as amphetamine, methylphenidate, and Noopept. However, this effect can occur to a lesser extent under the influence of certain cannabis strains and spontaneously during psychedelic states. It is also worth noting that the same compounds which induce this mind state at light to moderate dosages can often result in the opposite effect of thought disorganization at heavier dosages.[3][5][6]
Psychoactive substances
Compounds within our psychoactive substance index which may cause this effect include:
- 2-FA
- 2-FEA
- 2-FMA
- 3,4-CTMP
- 4-AcO-DMT
- 4F-MPH
- Amphetamine
- Armodafinil
- Ayahuasca
- Creatine
- Cyclazodone
- DMT
- Desoxypipradrol
- ETH-CAT
- ETH-LAD
- Ibogaine
- Lisdexamfetamine
- MDPV
- Methiopropamine
- Methylphenidate
- Prolintane
- Propylhexedrine
- Psilocin
- Psilocybin mushrooms
- SAM-e
- Theanine
Experience reports
Annectdotal reports which describe this effect with our experience index include:
- Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
- Experience:100-350mg - Phenylpiracetam in daily life
- Experience:2.5g Psilocybe Cubensis B+ strain - epiphany of nondualistic reality
- Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
- Experience:BK-2C-B - Various experiences
- Experience:FMA (37.5 mg, oral) - Never been this productive in my life
- Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
See also
- Responsible use
- Subjective effects index
- Thought disorganization
- Psychedelics - Subjective effects
- Dissociatives - Subjective effects
- Deliriants - Subjective effects
External links
References
- ↑ Diamond, Adele (2013). "Executive Functions". Annual Review of Psychology. 64 (1): 135–168. doi:10.1146/annurev-psych-113011-143750. ISSN 0066-4308.
- ↑ 2.0 2.1 Biederman, Joseph; Seidman, Larry J.; Petty, Carter R.; Fried, Ronna; Doyle, Alysa E.; Cohen, Daniel R.; Kenealy, Deborah C.; Faraone, Stephen V. (2008). "Effects of Stimulant Medication on Neuropsychological Functioning in Young Adults With Attention-Deficit/Hyperactivity Disorder". The Journal of Clinical Psychiatry. 69 (7): 1150–1156. doi:10.4088/JCP.v69n0715. ISSN 0160-6689.
- ↑ 3.0 3.1 Gupta, B.S. (1977). "Dextroamphetamine and measures of intelligence". Intelligence. 1 (3): 274–280. doi:10.1016/0160-2896(77)90010-1. ISSN 0160-2896.
- ↑ 4.0 4.1 Hellwig-Brida, Susanne; Daseking, Monika; Keller, Ferdinand; Petermann, Franz; Goldbeck, Lutz (2011). "Effects of Methylphenidate on Intelligence and Attention Components in Boys with Attention-Deficit/Hyperactivity Disorder". Journal of Child and Adolescent Psychopharmacology. 21 (3): 245–253. doi:10.1089/cap.2010.0041. ISSN 1044-5463.
- ↑ 5.0 5.1 Arnsten, Amy F.T.; Li, Bao-Ming (2005). "Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions". Biological Psychiatry. 57 (11): 1377–1384. doi:10.1016/j.biopsych.2004.08.019. ISSN 0006-3223.
- ↑ Lundqvist, T (2005). "Cognitive consequences of cannabis use: Comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions". Pharmacology Biochemistry and Behavior. 81 (2): 319–330. doi:10.1016/j.pbb.2005.02.017. ISSN 0091-3057.